Status:
UNKNOWN
Relief From Side Effects: Clinical Use of Electrodes With Direction
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
Boston Scientific Corporation
Conditions:
Deep Brain Stimulation
Directional Lead
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Deep Brain Stimulation (DBS) uses electrical pulses sent through a lead (insulated wire) to help stop unwanted symptoms in a variety of brain diseases, including the tremor seen in patients with Essen...
Detailed Description
Patients implanted with a DBS may experience unwanted side effects such as motor contractures, paresthesia, or dysarthria. This occurs when the electrical field of the stimulation spreads out beyond t...
Eligibility Criteria
Inclusion
- Participants must have been implanted with the DBS
- Participants must have been diagnosed with Essential Tremor
- Participants must experience negative side effects from their DBS which limit control over their tremor
- Participants must be able to receive benefit from their stimulator, but at the cost of negative side effects
Exclusion
- All individuals who meet criteria outlined in "inclusion criteria" may be eligible for this study
Key Trial Info
Start Date :
September 17 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2019
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT03795935
Start Date
September 17 2018
End Date
August 1 2019
Last Update
January 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Vancouver General Hospital
Vancouver, British Columbia, Canada, V5Z 4E3